P. Delgado-López

Genetics · 2016

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. Delgado-López trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Q. Ostrom
  2. H. Ohgaki
  3. P. Wen
  4. P. Kleihues

Papers from P. Delgado-López's perspective

Ordered by how strongly the researchers P. Delgado-López trusts endorse each paper. Same corpus, a different order for every researcher.

  1. An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
  2. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
  3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. (New England Journal of Medicine)
  4. MGMT gene silencing and benefit from temozolomide in glioblastoma. (New England Journal of Medicine)
  5. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (Cancer Cell)
  6. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. (The Lancet Oncology)
  7. IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas (Clinical Cancer Research)
  8. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. (Cancer Research)
  9. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. (Journal of Neurosurgery)
  10. The Definition of Primary and Secondary Glioblastoma (Clinical Cancer Research)

Their papers